本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Benitec Biopharma Limited

14.41
+0.82006.03%
盘后14.410.00000.00%19:47 EDT
成交量:5.71万
成交额:80.40万
市值:3.67亿
市盈率:-7.44
高:14.79
开:13.55
低:13.10
收:13.59
数据加载中...
2019/07/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/01/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/30

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2018/10/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/09/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/09/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/08/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/07/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/06/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2016/12/23

非美公司披露报告

Asx /纳斯达克宣布